S1PR2 is expressed on various cell types relevant to the TIME, including myeloid cells (macrophages, monocytes, neutrophils) and certain cancer cells, positioning it to potentially influence tumor-associated inflammation and progression (2, 29, 103). The gene discussed is S1PR2; the disease is cancer.